Wolfson Group, a global consumer wellness company, today announced the acquisition of a portfolio of established wellness brands, including PhenQ, TestoPrime, NooCube, and YourBiology, to accelerate its expansion across the United States. The move strengthens Wolfson Group's position in the growing health and wellness sector and creates a stronger platform for growth across retail, e-commerce, and international distribution.
The brands are already available to U.S. consumers through Amazon, with Wolfson Group now investing in broader market expansion through additional retail partnerships, enhanced consumer education, strategic distribution, and continued product innovation. The portfolio spans several of the fastest-growing areas of consumer wellness, including weight management, cognitive performance, gut health, healthy ageing, and men's wellbeing.
"The acquisition represents an exciting milestone in our long-term growth strategy," said Scott Dingwall, Founder and CEO of Wolfson Group. "These brands have built strong customer loyalty and proven demand across key wellness categories. By bringing them into the Wolfson Group family, we can accelerate investment, expand distribution and make these trusted products accessible to even more consumers across the United States."
The acquisition reflects Wolfson Group's commitment to building a diversified wellness ecosystem focused on preventative health and evidence-based nutrition. The company believes continued consumer demand for proactive wellness solutions presents significant opportunities for long-term growth in North America.
"We continue to see consumers taking greater ownership of their health and wellbeing," Dingwall added. "Our ambition is to build brands that people trust throughout every stage of their wellness journey. This acquisition gives us an even stronger foundation to deliver on that vision."
Wolfson Group plans to continue investing in product innovation, digital growth, retail partnerships, and international expansion as it scales the portfolio across the U.S. market. The acquisition underscores the company's strategy to tap into the growing consumer demand for science-led health products, leveraging the acquired brands' existing customer loyalty and market presence to drive growth.
For more information about Wolfson Group and its brands, visit their website at https://wolfson-group.com.
